Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Enterprise Value (2010 - 2026)

Innoviva's (INVA) quarterly Enterprise Value came in at -$603.1 million in Q1 2026, down 89.0% YoY from -$5.5 billion in Q1 2025, and down 9.46% on a QoQ basis from -$550.9 million in Q4 2025.

Analysis

Innoviva (INVA) Enterprise Value (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Enterprise Value data on file, last reported at -$603.1 million in Q1 2026.

  • Quarterly Enterprise Value fell 89.0% year-over-year to -$603.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$603.1 million (down 89.0% YoY) and the FY2025 annual result came in at -$550.9 million, down 80.66% from the prior year.
  • Enterprise Value declined to -$603.1 million in Q1 2026, from -$550.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$144.0 million in Q1 2023 to a low of -$603.1 million in Q1 2026.
  • A 5-year average of -$299.5 million and a median of -$283.6 million in 2022 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2022 — Enterprise Value slumped 1469.95% — and 2023, when it jumped 40.21%.
  • Tracing INVA's Enterprise Value over 5 years: stood at -$291.0 million in 2022, then surged by 33.51% to -$193.5 million in 2023, then plunged by 57.59% to -$305.0 million in 2024, then sank by 80.66% to -$550.9 million in 2025, then retreated by 9.46% to -$603.1 million in 2026.
  • The last three Enterprise Value figures came in at -$603.1 million (Q1 2026), -$550.9 million (Q4 2025), and -$476.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Bn
Mar 31, 2026 1.11 Bn
Dec 31, 2025 925.31 Mn
Sep 30, 2025 831.43 Mn
Jun 30, 2025 768.16 Mn
Mar 31, 2025 691.16 Mn
Dec 31, 2024 674.74 Mn
Sep 30, 2024 948.20 Mn
Jun 30, 2024 809.01 Mn
Mar 31, 2024 778.67 Mn
Dec 31, 2023 821.93 Mn
Sep 30, 2023 656.35 Mn
Jun 30, 2023 657.29 Mn
Mar 31, 2023 596.47 Mn
Dec 31, 2022 625.69 Mn
Sep 30, 2022 509.03 Mn
Jun 30, 2022 745.28 Mn
Mar 31, 2022 1.13 Bn
Dec 31, 2021 1.11 Bn
Sep 30, 2021 1.12 Bn